15-PGDH Activity Assay Kit (Fluorometric) (ab273327)
Key features and details
- Assay type: Enzyme activity (quantitative)
- Detection method: Fluorescent
- Platform: Microplate
- Sample type: Adherent cells, Suspension cells, Tissue
- Sensitivity: 1 µU
Overview
-
Product name
15-PGDH Activity Assay Kit (Fluorometric) -
Detection method
Fluorescent -
Sample type
Tissue, Adherent cells, Suspension cells -
Assay type
Enzyme activity (quantitative) -
Sensitivity
1 µU -
Assay duration
Multiple steps standard assay -
Product overview
15-PGDH Activity Assay Kit (Fluorometric) (ab273327) offers a rapid, simple, sensitive, and reliable test suitable for detecting as low as 1 µU of 15-Hydroxy prostaglandin dehydrogenase (15-PGDH; EC:1.1.1.141) activity.
In the assay, 15-PGDH oxidizes a substrate forming intermediates and NADH. The oxidation of NADH reduces a probe generating fluorescence at Ex/Em=535/587 nm. The activity of 15-PGDH is proportional to the fluorescent signal.
-
Platform
Microplate
Properties
-
Storage instructions
Store at -20°C. Please refer to protocols. -
Components 100 tests 15-PGDH Assay Buffer 1 x 25ml 15-PGDH Developer (Lyophilized) 1 vial 15-PGDH Positive Control 1 x 100µl 15-PGDH Substrate (in DMSO) 1 x 100µl NADH Standard (Lyophilized) 1 vial Probe (in DMSO) 1 x 200µl -
Research areas
-
Function
Prostaglandin inactivation. Contributes to the regulation of events that are under the control of prostaglandin levels. Catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4. Inhibits in vivo proliferation of colon cancer cells. -
Tissue specificity
Detected in colon epithelium (at protein level). -
Involvement in disease
Defects in HPGD are the cause of primary hypertrophic osteoathropathy autosomal recessive (PHOAR) [MIM:259100]; also known as pachydermoperiostosis autosomal recessive. Primary hypertrophic osteoarthropathy is characterized by digital clubbing, osterarthropathy, variable features of pachydermia, delayed closure of the fontanels, and congenital heart disease.
Defects in HPGD are the cause of cranioosteoarthropathy (COA) [MIM:259100]. Clinical features include infantile onset of swelling of the joints, digital clubbing, hyperhidrosis, delayed closure of the fontanels, periostosis, and variable patent ductus arteriosus. Pachydermia is not a prominent feature.
Defects in HPGD are a cause of isolated congenital nail clubbing (ICNC) [MIM:119900]; also called clubbing of digits or hereditary acropachy. ICNC is a rare genodermatosis characterized by enlargement of the nail plate and terminal segments of the fingers and toes, resulting from proliferation of the connective tissues between the nail matrix and the distal phalanx. It is usually symmetrical and bilateral (in some cases unilateral). In nail clubbing usually the distal end of the nail matrix is relatively high compared to the proximal end, while the nail plate is complete but its dimensions and diameter more or less vary in comparison to normal. There may be different fingers and toes involved to varying degrees. Some fingers or toes are spared, but the thumbs are almost always involved. -
Sequence similarities
Belongs to the short-chain dehydrogenases/reductases (SDR) family. -
Cellular localization
Cytoplasm. - Information by UniProt
-
Alternative names
- 15 hydroxyprostaglandin dehydrogenase [NAD+]
- 15 PGDH
- 15-hydroxyprostaglandin dehydrogenase [NAD+]
see all
Images
-
Typical standard curve – data provided for demonstration purposes only. A new standard curve must be generated for each assay performed.
-
Kinetic measurement of 15-PGDH Specific Activity in lysates prepared from mouse liver (50 µg) and 15-PGDH Positive Control.
-
15-PGDH specific activity of mouse lysates from liver (50 µg), kidney (16.5 µg) and lung (41 µg). Assays were performed following the kit protocol.